These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors. Wolf ML, Weng WK, Stieglbauer KT, Shah N, LeBien TW. J Immunol; 1993 Jul 01; 151(1):138-48. PubMed ID: 7686930 [Abstract] [Full Text] [Related]
4. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice. McKenna SD, Chen F, Lai L, Goldschneider I. J Immunol; 1998 Mar 01; 160(5):2272-9. PubMed ID: 9498767 [Abstract] [Full Text] [Related]
5. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Saeland S, Duvert V, Caux C, Pandrau D, Favre C, Vallé A, Durand I, Charbord P, de Vries J, Banchereau J. Exp Hematol; 1992 Jan 01; 20(1):24-33. PubMed ID: 1374342 [Abstract] [Full Text] [Related]
6. The CD24 antigen discriminates between pre-B and B cells in human bone marrow. Duperray C, Boiron JM, Boucheix C, Cantaloube JF, Lavabre-Bertrand T, Attal M, Brochier J, Maraninchi D, Bataille R, Klein B. J Immunol; 1990 Dec 01; 145(11):3678-83. PubMed ID: 1700990 [Abstract] [Full Text] [Related]
7. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. Wolf ML, Buckley JA, Goldfarb A, Law CL, LeBien TW. J Immunol; 1991 Nov 15; 147(10):3324-30. PubMed ID: 1719075 [Abstract] [Full Text] [Related]
8. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors. Ishii T, Nishihara M, Ma F, Ebihara Y, Tsuji K, Asano S, Nakahata T, Maekawa T. J Immunol; 1999 Oct 01; 163(7):3612-20. PubMed ID: 10490954 [Abstract] [Full Text] [Related]
9. Interleukin-7 contributes to human pro-B-cell development in a mouse stromal cell-dependent culture system. Taguchi T, Takenouchi H, Shiozawa Y, Matsui J, Kitamura N, Miyagawa Y, Katagiri YU, Takahashi T, Okita H, Fujimoto J, Kiyokawa N. Exp Hematol; 2007 Sep 01; 35(9):1398-407. PubMed ID: 17656007 [Abstract] [Full Text] [Related]
10. Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways. Sanz E, Muñoz-A N, Monserrat J, Van-Den-Rym A, Escoll P, Ranz I, Alvarez-Mon M, de-la-Hera A. Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5925-30. PubMed ID: 20231472 [Abstract] [Full Text] [Related]
11. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ. Exp Hematol; 1997 Oct 30; 25(11):1125-39. PubMed ID: 9328449 [Abstract] [Full Text] [Related]
12. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. Marshall AJ, Fleming HE, Wu GE, Paige CJ. J Immunol; 1998 Dec 01; 161(11):6038-45. PubMed ID: 9834086 [Abstract] [Full Text] [Related]
13. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. Stephan RP, Lill-Elghanian DA, Witte PL. J Immunol; 1997 Feb 15; 158(4):1598-609. PubMed ID: 9029095 [Abstract] [Full Text] [Related]
14. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S. Bone Marrow Transplant; 1998 Dec 15; 22 Suppl 5():S47-50. PubMed ID: 9989890 [Abstract] [Full Text] [Related]
15. Stromal cell-independent maturation of IL-7-responsive pro-B cells. Ray RJ, Stoddart A, Pennycook JL, Huner HO, Furlonger C, Wu GE, Paige CJ. J Immunol; 1998 Jun 15; 160(12):5886-97. PubMed ID: 9637501 [Abstract] [Full Text] [Related]
16. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues. Huang S, Chen Z, Yu JF, Young D, Bashey A, Ho AD, Law P. Stem Cells; 1999 Jun 15; 17(5):265-72. PubMed ID: 10527461 [Abstract] [Full Text] [Related]
17. IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics. Fauteux LJ, Osmond DG. J Immunol; 1996 Apr 01; 156(7):2376-83. PubMed ID: 8786294 [Abstract] [Full Text] [Related]
18. The effects of interleukin 7 (IL-7) on human bone marrow in vitro. Tushinski RJ, McAlister IB, Williams DE, Namen AE. Exp Hematol; 1991 Sep 01; 19(8):749-54. PubMed ID: 1678354 [Abstract] [Full Text] [Related]
19. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec 01; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
20. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). II. PPBSF is a covalently linked heterodimer of IL-7 and a Mr 30,000 cofactor. Lai L, Chen F, McKenna S, Goldschneider I. J Immunol; 1998 Mar 01; 160(5):2280-6. PubMed ID: 9498768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]